Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Pharmacol.

Sec. Renal Pharmacology

This article is part of the Research TopicAdvancing Diagnostic and Therapeutic Approaches for Kidney Dysfunction in Vascular Surgery PatientsView all 5 articles

Impact of Postoperative Flurbiprofen Axetil on Renal Function in Spontaneously Hypertensive Rats

Provisionally accepted
Liang  SunLiang Sun1,2Xiaoran  MaXiaoran Ma1Yuhui  JiangYuhui Jiang1Wanda  ZhangWanda Zhang3Yi  FengYi Feng1*
  • 1Department of Anesthesiology, Peking University People's Hospital, Beijing, China
  • 2Department of Anesthesiology, Peking University People's Hospital Shijiazhuang Campus, Shijiazhuang People's Hospital, Shijiazhang, China
  • 3Arthritis Clinic and Research Center, Peking University People's Hospital, Beijing, China, Beijing, China

The final, formatted version of the article will be published soon.

Abstract Background: Flurbiprofen axetil (FA) is a nonsteroidal anti-inflammatory drug frequently used in postoperative analgesia. However, limited data exist regarding its impact on renal profiles. Here we determine the potential impact of postoperative FA on renal function in spontaneously hypertensive (SH) rats. Methods: A plantar incision model was established to mimic post-surgical pain in SH rats. Animals were randomly assigned to groups called vehicle (fat emulsion, 0.5 mL/d), low-dose FA (H12.5, 12.5 mg/kg/d), medium-dose FA (H25, 25 mg/kg/d) or high-dose FA (H50, 50 mg/kg/d). Analogously, 40 male Wistar Kyoto (WKY) rats were included as controls in groups called vehicle, C12.5, C25, and C50. The vehicle and different doses of FA were administered from the day of surgery through postoperative day 2 (POD2). Paw withdrawal thresholds (PWTs) were measured before and after incision. Urinary N-acetyl-β-D-glucosaminidase (NAG), serum creatinine (SCr), and Cystatin C (Cys C) were measured. Animals were sacrificed for renal pathology analysis on POD7. Results: PWTs exhibited a dose-dependent increase after postoperative administration of FA on POD1 and POD2, but a ceiling effect at the medium dose in both SH and WKY rats. Compared with the vehicle group, the levels of SCr in the C50, H25, and H50 groups were significantly increased on POD2 and POD7 (all P<0.01). The concentration of Cys C in C12.5, C25, and C50 groups, as well as H12.5, H25, and H50 groups on POD2, were increased in a dose-dependent manner (all P<0.05), similar trend was detected in H25, and H50 groups on POD7. Urine NAG levels in the H12.5, H25 and H50 groups on POD2, as well as H25 and H50 groups on POD7 were elevated in comparison with the vehicle groups (all P<0.05). Partial glomerular and tubular damage was found in the H25 group. Extensive renal impairments were observed in the C50 and H50 groups. Conclusion: Medium-dose FA effectively alleviates postoperative pain and achieves a ceiling effect in SH rats. FA decreases glomerular and tubular function to a certain extent in both normo-and hypertensive rats. Renal impairment is detectable earlier after surgery in hypertensive rats, even at the lowest FA dose applied here.

Keywords: Flurbiprofen axetil, glomerular, Hypertension, Pain behavior, Renal function, Tubular

Received: 15 Aug 2025; Accepted: 03 Dec 2025.

Copyright: © 2025 Sun, Ma, Jiang, Zhang and Feng. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Yi Feng

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.